Ca2+ regulatory mechanisms of exercise protection against coronary artery disease in metabolic syndrome and diabetes

Journal of Applied Physiology

Volumn 111, Issue 2, 2011, Pages 573-586

  Sturek, Michael ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcification; K+ channel; Nucleus; Plasmalemma Ca2+ ATPase; Proliferation; Sarcoplasmic reticulum Ca2+ ATPase; Subcellular localization; Transient receptor potential canonical channel; Voltage gated Ca2+ channel

Indexed keywords

CALCIUM;

ADAPTATION; ANIMAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMAN; METABOLIC SYNDROME X; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SKELETAL MUSCLE; SWINE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CALCIUM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; HUMANS; METABOLIC SYNDROME X; MOTOR ACTIVITY; MUSCLE, SKELETAL; SWINE;

EID: 79960237085     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00373.2011     Document Type: Review

References (132)

1. ACCORD Study Group; Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, Probstfield JL, Cushman WC, Ginsberg HN, Bigger JT, Grimm RH Jr, Byington RP, Rosenberg YD, Friedewald WT. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 364: 818-828, 2011.
2. 2+-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res 90: 1114-1121, 2002. (Pubitemid 34627911)
3. Belardinelli R, Paolini I, Cianci G, Piva R, Georgiou D, Purcaro A. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 37: 1891-1900, 2001. (Pubitemid 32499976)
4. Bell LN, Lee L, Saxena R, Bemis KG, Wang M, Theodorakis JL, Vuppalanchi R, Alloosh M, Sturek M, Chalasani N. Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Am J Physiol Gastrointest Liver Physiol 298: G746-G754, 2010.
5. Bellinger DA, Merricks EP, Nichols TC. Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications. ILAR J 47: 243-258, 2006. (Pubitemid 43986033)
6. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med 234: 683-692, 2009.
7. 2+ entry dependent on TRPC1. Circ Res 93: 839-847, 2003. (Pubitemid 37363058)
8. Borbouse L, Dick GM, Asano S, Bender SB, Dincer UD, Payne GA, Neeb ZP, Bratz IN, Sturek M, Tune JD. Impaired function of coronary BKCa channels in metabolic syndrome. Am J Physiol Heart Circ Physiol 297: H1629-H1637, 2009.
9. + channels to ischemic coronary vasodilation. Am J Physiol Heart Circ Physiol 298: H1182-H1189, 2010.
10. Borbouse L, Dick GM, Payne GA, Payne BD, Svendsen MC, Neeb ZP, Alloosh M, Bratz IN, Sturek M, Tune JD. Contribution of BKCa channels to local metabolic coronary vasodilation: effects of metabolic syndrome. Am J Physiol Heart Circ Physiol 298: H966-H973, 2010.
11. Boullion RD, Mokelke EA, Wamhoff BR, Otis CR, Wenzel J, Dixon JL, Sturek M. Porcine model of diabetic dyslipidemia: Insulin and feed algorithms for mimicking diabetes in humans. Comp Med 53: 42-52, 2003. (Pubitemid 36323513)
12. Bowles DK, Heaps CL, Turk JR, Maddali KK, Price EM. Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation. J Appl Physiol 96: 2240-2248, 2004. (Pubitemid 38661508)
13. Bowles DK, Wamhoff BR. Coronary smooth muscle adaptation to exercise: does it play a role in cardioprotection? Acta Physiol Scand 178: 117-121, 2003. (Pubitemid 36718162)
14. Bratz IN, Dick GM, Tune JD, Edwards JM, Neeb ZP, Dincer UD, Sturek M. Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome. Am J Physiol Heart Circ Physiol 294: H2489-H2496, 2008.
15. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 24: 1266-1271, 2004. (Pubitemid 38880019)
16. Casscells W, Naghavi M, Willerson JT. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107: 2072-2075, 2003. (Pubitemid 36532184)
17. Christoffersen BO, Grand N, Golozoubova V, Svendsen O, Raun K. Gender-associated differences in metabolic syndrome-related parameters in Gottingen minipigs. Comp Med 57: 493-504, 2007. (Pubitemid 351773344)
18. Clark BA, Alloosh M, Wenzel JW, Sturek M, Kostrominova TY. Effect of diet-induced obesity and metabolic syndrome on skeletal muscles of Ossabaw miniature swine. Am J Physiol Endocrinol Metab 300: E848-E857, 2011.
19. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, Braun B. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care 33: 2692-2696, 2010.
20. Committee to Develop a Resource Book for Animal Exercise Protocols. Resource Book for the Design of Animal Exercise Protocols. Bethesda, MD: Am. Physiol. Soc., 2006.
21. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C, Stas S, Sowers JR. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 293: H2009-H2023, 2007. (Pubitemid 47605846)
22. Diamond J. The double puzzle of diabetes. Nature 423: 599-602, 2003. (Pubitemid 36713209)
23. 2+ store in porcine coronary artery smooth muscle. Diabetes 45: 876-880, 1996. (Pubitemid 26225501)
24. Dixon JL, Shen S, Vuchetich JP, Wysocka E, Sun G, Sturek M. Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. J Lipid Res 43: 1618-1629, 2002. (Pubitemid 35168276)
25. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 19: 2981-2992, 1999. (Pubitemid 30029828)
26. Dyson M, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female Ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
27. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113: 2943-2946, 2006. (Pubitemid 44297236)
28. 1 receptors in neointimal hyperplasia and in-stent stenosis in Ossabaw miniature swine. Cor Art Dis 19: 27-31, 2008. (Pubitemid 351339963)
29. 2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc Res 85: 631-640, 2010.
30. Erbs S, Linke A, Hambrecht R. Effects of exercise training on mortality in patients with coronary heart disease. Cor Art Dis 17: 219-225, 2006. (Pubitemid 44324830)
31. Fleenor BS, Bowles DK. Exercise training decreases the size and alters the composition of the neointima in a porcine model of percutaneous transluminal coronary angioplasty (PTCA). J Appl Physiol 107: 937-945, 2009.
32. Flum DR, Devlin A, Wright AS, Figueredo E, Alyea E, Hanley PW, Lucas MK, Cummings DE. Development of a porcine Roux-en-Y gastric bypass survival model for the study of post-surgical physiology. Obesity Surg 17: 1332-1339, 2007. (Pubitemid 351339483)
33. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28: 1769-1778, 2005. (Pubitemid 40923091)
34. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome amoung U.S. adults. Diabetes Care 27: 2444-2449, 2004. (Pubitemid 39281399)
35. Fullenkamp AM, Bell LN, Robbins RD, Lee L, Saxena R, Alloosh M, Klaunig JE, Mirmira RG, Sturek M, Chalasani N. Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine. Pancreas 40: 438-443, 2011.
36. Gerrity RG, Natarajan R, Nadler JL, Kimsey T. Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50: 1654-1665, 2001. (Pubitemid 33639607)
37. Goldberg IJ, Dansky HM. Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol 26: 1693-1701, 2006. (Pubitemid 44305321)
38. Grundy SM, Brewer HB, Cleeman JI, Smith SC Jr, Lenfant C. Definition of the metabolic syndrome. Circulation 109: 433-438, 2004.
39. Hainsworth DP, Katz ML, Sanders DA, Sanders DN, Wright EJ, Sturek M. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Comp Med 52: 523-529, 2002. (Pubitemid 36091702)
40. Hall JE. The kidney, hypertension, obesity. Hypertension 41: 625-633, 2003.
41. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 109: 1371-1378, 2004. (Pubitemid 38387823)
42. Haskell WL, Sims C, Myll J, Bortz WM, St Goar FG, Alderman EL. Coronary artery size and dilating capacity in ultradistance runners. Circulation 87: 1076-1082, 1993. (Pubitemid 23110378)
43. Hill AB. The environment and disease: association or causation? Proc R Soc Med 58: 295-300, 1965.
44. Hill BJF, Dixon JL, Sturek M. Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. Atherosclerosis 159: 117-124, 2001. (Pubitemid 33016628)
45. Hill BJF, Price EM, Dixon JL, Sturek M. Increased calcium buffering in coronary smooth muscle cells from diabetic dyslipidemic pigs. Atherosclerosis 167: 15-23, 2003. (Pubitemid 36255631)
46. Hill BJF, Wamhoff BR, Sturek M. Functional nucleotide receptor expression and sarcoplasmic reticulum morphology in dedifferentiated porcine coronary smooth muscle cells. J Vasc Res 38: 432-443, 2001. (Pubitemid 34701456)
47. Holvoet P, Davey PC, De Keyzer D, Doukoure M, Deridder E, Bochaton-Piallat ML, Gabbiani G, Beaufort E, Bishay K, Andrieux N, Benhabiles N, Marguerie G. Oxidized low-density lipoprotein correlates positively with Toll-like receptor 2 and interferon regulatory factor-1 and inversely with superoxide dismutase-1 expression: studies in hypercholesterolemic swine and THP-1 cells. Arterioscler Thromb Vasc Biol 26: 1558-1565, 2006. (Pubitemid 44288983)
48. Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50, Suppl: S172-S177, 2009.
49. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadan-Diehl C, Goldberg IJ. Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100: 1415-1427, 2007. (Pubitemid 46834754)
50. Jacobsson L. Comparison of experimental hypercholesterolemia and atherosclerosis in male and female mini-pigs of the Gottingen strain. Artery 16: 105-117, 1989. (Pubitemid 19069050)
51. Jaffe IZ, Tintut Y, Newfell BG, Demer LL, Mendelsohn ME. Mineralocorticoid receptor activation promotes vascular cell calcification. Arterioscler Thromb Vasc Biol 27: 799-805, 2007. (Pubitemid 46606709)
52. Johansen T, Hansen HS, Richelsen B, Malmlof R. The obese Gottingen minipig as a model of the metabolic syndrome: dietary effects on obesity, insulin sensitivity, and growth hormone profile. Comp Med 51: 150-155, 2001. (Pubitemid 32435988)
53. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 48: 1684-1699, 2005. (Pubitemid 41317821)
54. Karanian JW, Peregoy JA, Chiesa OA, Murray TL, Ahn C, Pritchard WF. Efficiency of drug delivery to the coronary arteries in swine is dependent on the route of administration: assessment of luminal, intimal, and adventitial coronary artery and venous delivery methods. J Vasc Interv Radiol 21: 1555-1564, 2010.
55. Kramsch DM, Aspen AJ, Abramowitz BM, Kreimendahl T, Wood WB Jr. Reduction of coronary atherosclerosis by moderate conditioning exercise in monkeys on an atherogenic diet. N Engl J Med 305: 1483-1489, 1981. (Pubitemid 12244202)
56. Kreutz RP, Alloosh M, Mansour K, Neeb ZP, Kreutz Y, Flockhart DA, Sturek M. Morbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivity. Diabetes Metab Syndr Obes 4: 99-105, 2011.
57. Kumar B, Dreja K, Shah SS, Cheong A, Xu SZ, Sukumar P, Naylor J, Forte A, Cipollaro M, McHugh D, Kingston PA, Heagerty AM, Munsch CM, Bergdahl A, Hultgardh-Nilsson A, Gomez MF, Porter KE, Hellstrand P, Beech DJ. Upregulated TRPC1 channel in vascular injury in vivo and its role in human neointimal hyperplasia. Circ Res 98: 557-563, 2006.
58. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN, Murphy CN, Carter DB, Hawley RJ, Prather RS. Production of α-1,3-Galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295: 1089-1092, 2003.
59. Landsberg JW, Yuan JX. Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. News Physiol Sci 19: 44-50, 2004.
60. Langohr IM, HogenEsch H, Stevenson GW, Sturek M. Vascularassociated lymphoid tissue in swine (Sus scrofa). Comp Med 58: 168-173, 2008.
61. Larsen MO, Juhl CB, Porksen N, Gotfredsen CF, Carr RD, Ribel U, Wilken M, Rolin B. Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Gottingen minipigs. Am J Physiol Endocrinol Metab 288: E412-E421, 2005. (Pubitemid 40110651)
62. Larsen MO, Rolin B. Use of the Gottingen minipig as a model of diabetes with special focus on type 1 diabetes research. ILAR J 45: 303-313, 2004.
63. Larsen MO, Rolin B, Raun K, Bjerre Knudsen L, Gotfredsen CF, Bock T. Evaluation of beta-cell mass and function in the Gottingen minipig. Diabetes Obesity Metab 9, Suppl 2: 170-179, 2007. (Pubitemid 47543139)
64. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig: results from a pilot study. Ann NY Acad Sci 967: 414-423, 2002. (Pubitemid 34721927)
65. Larsen MO, Rolin B, Sturis J, Wilken M, Carr RD, Porksen N, Gotfredsen CF. Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Gottingen minipigs in vivo. Am J Physiol Endocrinol Metab 290: E670-E677, 2006.
66. Le T, Langohr IM, Locker MJ, Sturek M, Cheng JX. Label-free molecular imaging of atherosclerotic lesions using multimodal nonlinear optical microscopy. J Biomed Opt 12: 054007, 2007.
67. 2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic swine are prevented by atorvastatin. J Pharmacol Exp Ther 306: 132-140, 2003. (Pubitemid 36734366)
68. Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, Sturek M, Chalasani N. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology 50: 56-67, 2009.
69. Li J, Sukumar P, Milligan CJ, Kumar B, Ma ZY, Munsch CM, Jiang LH, Porter KE, Beech DJ. Interactions, functions, and independence of plasma membrane STIM1 and TRPC1 in vascular smooth muscle cells. Circ Res 103: e97-e104, 2008.
70. Libby P, Plutzky J. Diabetic macrovascular disease: The glucose paradox?Circulation 106: 2760-2763, 2002. (Pubitemid 35396971)
71. Link RP, Pedersoli WM, Safanie AH. Effect of exercise on development of atherosclerosis in swine. Atherosclerosis 15: 107-122, 1972.
72. + current in arterial smooth muscle cells from aldosterone-salt hypertensive rats. Am J Physiol Heart Circ Physiol 269: H1246-H1257, 1995.
73. Lloyd PG, Sheehy AF, Edwards JM, Mokelke EA, Sturek M. Leukemia inhibitory factor is upregulated in coronary arteries of Ossabaw miniature swine after stent placement. Cor Art Dis 19: 217-226, 2008.
74. Long X, Bratz IN, Alloosh M, Edwards JM, Sturek M. Short-term exercise training prevents micro- and macrovascular disease following coronary stenting. J Appl Physiol 108: 1766-1774, 2010.
75. Long X, Mokelke EA, Neeb ZP, Alloosh M, Edwards JM, Sturek M. Adenosine receptor regulation of coronary blood flow in Ossabaw miniature swine. J Pharmacol Exp Ther 335: 781-787, 2010.
76. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrology 20: 1453-1464, 2009.
77. + current. Am J Physiol Heart Circ Physiol 288: H1233-H1241, 2005. (Pubitemid 40270029)
78. + channels in diabetic dyslipidemic pigs is prevented by exercise. J Appl Physiol 95: 1179-1193, 2003. (Pubitemid 37034016)
79. Mokelke EA, Hu Q, Turk JR, Sturek M. Enhanced contractility in coronary arteries of diabetic pigs is prevented by exercise. Equine Comp Exercise Physiol 1: 71-80, 2004.
80. Mokelke EA, Wang M, Sturek M. Exercise training enhances coronary smooth muscle cell sodium-calcium exchange activity in diabetic dyslipidemic Yucatan swine. Ann NY Acad Sci 976: 335-337, 2002. (Pubitemid 36126911)
81. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 116: 2110-2118, 2007. (Pubitemid 350060348)
82. Morgan KP, Kapur A, Beatt KJ. Anatomy of coronary disease in diabetic patients: an explanation for poorer outcomes after percutaneous coronary intervention and potential target for intervention. Heart 90: 732-738, 2004. (Pubitemid 38813629)
83. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 43: 632-641, 2000. (Pubitemid 30322081)
84. Neeb ZP, Edwards JM, Alloosh MA, Long X, Mokelke EA, Sturek M. Metabolic syndrome and coronary artery disease in Ossabaw compared with Yucatan swine. Comp Med 60: 300-315, 2010.
85. 2+ influx and the development of coronary artery disease (Abstract). FASEB J 22: 1152.17, 2008.
86. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev AD, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science 270: 633-637, 1995.
87. Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol 52: 255-262, 2008. (Pubitemid 351957849)
88. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, for the ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295: 1556-1565, 2006.
89. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-induced insulin resistance in diabetic dyslipidemic Yucatan swine. Comp Med 53: 53-64, 2003. (Pubitemid 36323514)
90. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84: 767-801, 2004. (Pubitemid 38823766)
91. Paderi JE, Stuart K, Sturek M, Park K, Panitch A. The inhibition of platelet adhesion and activation on collagen during balloon angioplasty by collagen-binding peptidoglycans. Biomaterials 32: 2516-2523, 2011.
92. Payne GA, Borbouse L, Kumar S, Neeb Z, Alloosh M, Sturek M, Tune JD. Epicardial perivascular adipose-derived leptin exacerbates coronary endothelial dysfunction in metabolic syndrome via a protein kinase C-â pathway. Arterioscler Thromb Vasc Biol 30: 1711-1717, 2010.
93. Phillips RW, Panepinto LM, Spangler R, Westmoreland N. Yucatan miniature swine as a model for the study of human diabetes-mellitus. Diabetes 31: 30-36, 1982. (Pubitemid 12128683)
94. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature 451: 904-913, 2008. (Pubitemid 351301745)
95. Rector RS, Thomas TR, Liu Y, Henderson KK, Holiman DA, Sun GY, Sturek M. Effect of exercise on postprandial lipemia following a higher calorie meal in Yucatan miniature swine. Metabolism 53: 1021-1026, 2003. (Pubitemid 38988287)
96. Richardson MR, Lai X, Dixon JL, Sturek M, Witzmann FA. Diabetic dyslipidemia and exercise alter the plasma low density lipoproteome in Yucatan pigs. Proteomics 9: 2468-2483, 2008.
97. Rusch NJ. BK channels in cardiovascular disease: a complex story of channel dysregulation. Am J Physiol Heart Circ Physiol 297: H1580-H1582, 2009.
98. Sacks HS. Weight loss in obesity reduces epicardial fat thickness; so what? J Appl Physiol 106: 1-2, 2009.
99. Schuler G, Hambrecht R, Schlierf G, Niebauer J, Hauer K, Neumann J, Hoberg E, Drinkmann A, Bacher F, Grunze M, Kübler W. Regular physical exercise and low-fat diet: effects on progression of coronary artery disease. Circulation 86: 1-11, 1992.
100. Sen L, Bialecki RA, Smith E, Smith TW, Colucci WS. Cholesterol increases the L-type voltage-sensitive calcium channel current in arterial smooth muscle cells. Circ Res 71: 1008-1014, 1992.
101. 2 receptor in coronary artery smooth muscle cells. Mol Pharmacol 66: 1265-1274, 2004. (Pubitemid 39411066)
102. Stehno-Bittel L, Laughlin MH, Sturek M. Exercise training alters Ca release from coronary smooth muscle sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol 259: H643-H647, 1990. (Pubitemid 20259445)
103. Stehno-Bittel L, Sturek M. Spontaneous sarcoplasmic reticulum calcium release and extrusion from bovine, not porcine, coronary artery smooth muscle. J Physiol (Lond) 451: 49-78, 1992.
104. Steinberger J, Daniels SR. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 107: 1448-1453, 2003. (Pubitemid 36350747)
105. Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis 110, Suppl: S27-S33, 1994.
106. Stern S, Bayes de Luna A. Coronary artery spasm: a 2009 update. Circulation 119: 2531-2534, 2009.
107. Sturek M, Alloosh M, Wenzel J, Byrd JP, Edwards JM, Lloyd PG, Tune JD, March KL, Miller MA, Mokelke EA, Brisbin IL Jr. Ossabaw Island miniature swine: cardiometabolic syndrome assessment. In: Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental Techniques, edited by Swindle MM. Boca Raton, FL: CRC, 2007, p. 397-402.
108. Sturek M, Kunda K, Hu Q. Sarcoplasmic reticulum buffering of myoplasmic calcium in bovine coronary artery smooth muscle. J Physiol 451: 25-48, 1992.
109. Sturek M, Mokelke EA, Sindermann JR, Adam LP, March KL. Molecular and cellular physiology of differentiated vascular smooth muscle. In: Cardiovascular Medicine, edited by Willerson JT, Cohn JN, Wellens HJJ, Holmes DR. London: Springer-Verlag, 2006, p. 1511-1523.
110. Takahashi Y, Watanabe H, Murakami M, Ohba T, Radovanovic M, Ono K, Iijima T, Ito H. Involvement of transient receptor potential canonical 1 (TRPC1) in angiotensin II-induced vascular smooth muscle cell hypertrophy. Atherosclerosis 195: 287-296, 2007. (Pubitemid 350087957)
111. + channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 291: H2493-H2503, 2006.
112. Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 28: 1084-1089, 2008.
113. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
114. Timmers L, Sluijter JPG, Verlaan CWJ, Steendijk P, Cramer MJ, Emons M, Strijder C, Grundeman PF, Sze SK, Hua L, Piek JJ, Borst C, Pasterkamp G, de Kleijn DPV. Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig. Circulation 115: 326-332, 2007. (Pubitemid 46148507)
115. Touchard AG, Schwartz RS. Preclinical restenosis models: challenges and successes. Toxicol Pathol 34: 11-18, 2006.
116. Turk JR, Carroll JA, Laughlin MH, Thomas TR, Casati J, Bowles DK, Sturek M. C-reactive protein correlates with macrophage accumulation in coronary arteries of hypercholesterolemic pigs. J Appl Physiol 95: 1301-1304, 2003. (Pubitemid 37034029)
117. Underwood FB, Laughlin MH, Sturek M. Altered control of calcium in coronary smooth muscle cells by exercise training. Med Sci Sports Exerc 26: 1230-1238, 1994. (Pubitemid 24319182)
118. Van Breemen C, Chen Q, Laher I. Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol Sci 16: 98-105, 1995.
119. Varga O, Harangi M, Olsson IAS, Hansen AK. Contribution of animal models to the understanding of the metabolic syndrome: a systematic overview. Obesity Rev 11: 792-807, 2009.
120. 2+ signaling. Am J Physiol Heart Circ Physiol 283: H2397-H2410, 2002. (Pubitemid 35345944)
121. 2+ channels modulate expression of smooth muscle differentiation marker genes via a Rho kinase/myocardin/SRF-dependent mechanism. Circ Res 95: 406-414, 2004. (Pubitemid 39100459)
122. 2+ signaling associated with diabetic dyslipidemia. J Vasc Res 39: 208-220, 2002. (Pubitemid 34827788)
123. Wamhoff BR, Bowles DK, Owens GK. Excitation-transcription coupling in arterial smooth muscle. Circ Res 98: 868-878, 2006.
124. Wang HW, Langohr IM, Sturek M, Cheng JX. Imaging and quantitative analysis of atherosclerotic lesions by CARS-based multimodal nonlinear optical microscopy. Arterioscler Thromb Vasc Biol 29: 1342-1348, 2009.
125. Wang HW, Simianu V, Locker MJ, Cheng JX, Sturek M. Stentinduced coronary artery stenosis characterized by multimodal nonlinear optical microscopy. J Biomed Opt 16: 021110, 2011.
126. Waxman S, Ishibashi F, Muller JE. Detection and treatment of vulnerable plaques and vulnerable patients: novel approaches to prevention of coronary events. Circulation 114: 2390-2411, 2006. (Pubitemid 44848285)
127. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072, 2005. (Pubitemid 43113437)
128. Witczak CA, Mokelke EA, Boullion RD, Wenzel J, Keisler DH, Sturek M. Noninvasive measures of body fat percentage in male Yucatan swine. Comp Med 55: 445-451, 2005.
129. Witczak CA, Sturek M. Exercise prevents diabetes-induced impairment in superficial buffer barrier in porcine coronary smooth muscle. J Appl Physiol 96: 1069-1079, 2004. (Pubitemid 38248685)
130. 2+ influx. Med Sci Sports Exerc 37: 1119-1125, 2005. (Pubitemid 40981672)
131. 2+ dysregulation in coronary smooth muscle from diabetic dyslipidemic Yucatan swine. J Appl Physiol 101: 752-762, 2006. (Pubitemid 44352285)
132. Ziegler MA, DiStasi MR, Bills RG, Miller SJ, Alloosh M, Murphy MP, Akingba AG, Sturek M, Dalsing MC, Unthank JL. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 17: 1-18, 2010.